Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Emergent BioSolutions acquires opioid overdose company

August 31, 2018 6:55 PM UTC

Biodefense company Emergent BioSolutions Inc. (NYSE:EBS) will acquire opioid overdose and addiction company Adapt Pharma Ltd. (Dublin, Ireland) for $635 million up front, comprising $575 million in cash and $60 million in stock. Adapt shareholders are also eligible for $100 million in sales milestones.

According to BioCentury's BCIQ database, the move is Emergent's first in the opioid overdose space...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article